Insider Stock Trading History of Deshpande Milind


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Deshpande Milind since year 2005. The trader's CIK number is 1378588. At the time of this reporting, Deshpande Milind is the President and CEO of Achillion Pharmaceuticals Inc . (stock ticker symbol ACHN). See this page for all insider trading activities at Achillion Pharmaceuticals Inc .


Stock purchases, sales, and option exercises reported by insider Deshpande Milind since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2015-01-21 ACHN Achillion Pharmaceuticals Inc Option Ex 100,000 3.02 302,000
2015-01-21 ACHN Achillion Pharmaceuticals Inc Sale 100,000 15.00 1,500,000
2014-08-18 ACHN Achillion Pharmaceuticals Inc Option Ex 216,624 2.86 619,111
2014-08-18 ACHN Achillion Pharmaceuticals Inc Sale 216,624 10.00 2,166,240
2012-03-15 ACHN Achillion Pharmaceuticals Inc Sale 5,312 10.70 56,838
2012-03-15 ACHN Achillion Pharmaceuticals Inc Option Ex 5,312 1.05 5,577
2012-01-09 ACHN Achillion Pharmaceuticals Inc Sale 10,625 9.34 99,237
2012-01-09 ACHN Achillion Pharmaceuticals Inc Option Ex 10,625 1.05 11,156
2011-06-28 ACHN Achillion Pharmaceuticals Inc Option Ex 49,688 1.46 72,643
2011-06-28 ACHN Achillion Pharmaceuticals Inc Sale 49,688 8.28 411,267
2011-06-22 ACHN Achillion Pharmaceuticals Inc Sale 10,800 7.51 81,064
2011-06-23 ACHN Achillion Pharmaceuticals Inc Sale 4,825 7.50 36,201
2011-05-27 ACHN Achillion Pharmaceuticals Inc Option Ex 47,800 1.05 50,190
2011-05-27 ACHN Achillion Pharmaceuticals Inc Sale 47,800 7.01 335,269

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Deshpande Milind (President and CEO of Achillion Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.